PLK1 and Sepsis: These findings enhance understanding of the mechanism of sepsis‐induced skeletal muscle atrophy and provide evidence that the PLK1‐AKT pathway may be a novel therapeutic target to relieve skeletal muscle atrophy induced by sepsis.